Structure–Activity Relationship of N-(2-(Piperidin-1-yl)phenyl)benzene-1,4-disulfonamides as TRPML1 Agonists

Transient receptor potential mucolipin 1 (TRPML1) is a lysosomal Ca2+ channel that regulates lysosomal trafficking, autophagy, and membrane repair. Its pharmacological activation represents a promising strategy for treating lysosomal dysfunction-related diseases, including lysosomal storage disorders, neurodegenerative diseases, muscular dystrophies, infectious diseases, and inflammatory disorders. However, existing TRPML1 agonists suffer from limitations that restrict their utility as in vivo probes and therapeutic leads. We report a comprehensive structure–activity relationship (SAR) study of N-(2-(piperidin-1-yl)phenyl)benzene-1,4-disulfonamides that delivered potent, selective, and pharmacokinetically improved TRPML1 agonists. Systematic scaffold optimization revealed key structural determinants of channel activation, yielding substantial potency gains alongside improved physicochemical, metabolic, and pharmacokinetic properties. Refinement of the aryl sulfonamide substituents and piperidine-containing moieties established clear SAR trends that enhanced cellular activity. Lead compounds exhibited robust TRPML1 agonism, high selectivity over related TRP channels, and in vivo-compatible pharmacokinetics. These studies validate this scaffold as a privileged chemotype for TRPML1 activation, providing optimized chemical probes for investigating TRPML1 biology and a foundation for therapeutic development across multiple indications.

Authors

Institutions

Publication Details

Journal
ACS Omega
Published
2026-11-20
DOI
https://doi.org/10.1021/acsomega.6c10058
Primary Topic
Calcium signaling and nucleotide metabolism
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Structure–Activity Relationship of N-(2-(Piperidin-1-yl)phenyl)benzene-1,4-disulfonamides as TRPML1 Agonists

Konstantinos Afratis, Xiaoli Zhang, Noel T Southall, Samarjit Patnaik et al.
ACS Omega
Calcium signaling and nucleotide metabolism
article

Structure–Activity Relationship of N-(2-(Piperidin-1-yl)phenyl)benzene-1,4-disulfonamides as TRPML1 Agonists

Konstantinos Afratis, Xiaoli Zhang, Noel T Southall, Samarjit Patnaik, Juan Marugán, David N. Greenblott, Mark J. Henderson, Abhijeet Kapoor, Raul Calvo, Haoxing Xu, Lu Yu, Pranav Shah, Sarah Gray Castle, Saket Bikmal, Amy Wang, Dara Sypes, Natalia Martinez, Amanda Liu, Xin Xu, Marc Ferrer, Xin Hu
article en

Abstract

Transient receptor potential mucolipin 1 (TRPML1) is a lysosomal Ca2+ channel that regulates lysosomal trafficking, autophagy, and membrane repair. Its pharmacological activation represents a promising strategy for treating lysosomal dysfunction-related diseases, including lysosomal storage disorders, neurodegenerative diseases, muscular dystrophies, infectious diseases, and inflammatory disorders. However, existing TRPML1 agonists suffer from limitations that restrict their utility as in vivo probes and therapeutic leads. We report a comprehensive structure–activity relationship (SAR) study of N-(2-(piperidin-1-yl)phenyl)benzene-1,4-disulfonamides that delivered potent, selective, and pharmacokinetically improved TRPML1 agonists. Systematic scaffold optimization revealed key structural determinants of channel activation, yielding substantial potency gains alongside improved physicochemical, metabolic, and pharmacokinetic properties. Refinement of the aryl sulfonamide substituents and piperidine-containing moieties established clear SAR trends that enhanced cellular activity. Lead compounds exhibited robust TRPML1 agonism, high selectivity over related TRP channels, and in vivo-compatible pharmacokinetics. These studies validate this scaffold as a privileged chemotype for TRPML1 activation, providing optimized chemical probes for investigating TRPML1 biology and a foundation for therapeutic development across multiple indications.

ACS Omega
National Institutes of Health (US), University of Michigan (US), National Center for Advancing Translational Sciences (US), Zhejiang University (CN)
Calcium signaling and nucleotide metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon